SCL ScienceSCL사이언스
246960 · KOSDAQ · ₩246960 · SCL사이언스
₩2,140▼ ₩70 (3.17%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩22B | ₩4.7B | ₩1.3B | ₩370M | ₩507M |
| Cost of sales | ₩18B | ₩2.9B | ₩1.1B | ₩301M | ₩324M |
| Gross profit | ₩4.2B | ₩1.8B | ₩208M | ₩68M | ₩183M |
| Operating income | −₩3.4B | −₩3.7B | −₩4B | −₩4.6B | −₩4.5B |
| Net income | −₩4.1B | −₩3.7B | −₩5B | −₩6B | −₩5B |
| Net income to shareholders | −₩3.9B | −₩3.7B | −₩5B | −₩6B | −₩5B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩80B | ₩24B | ₩30B | ₩31B | ₩32B |
| Current assets | ₩24B | ₩5.5B | ₩11B | ₩5.5B | ₩11B |
| Cash and equivalents | ₩4.2B | ₩937M | ₩5B | ₩1.8B | ₩1B |
| Total liabilities | ₩56B | ₩8.5B | ₩11B | ₩18B | ₩22B |
| Current liabilities | ₩25B | ₩3.5B | ₩3.4B | ₩2.5B | ₩657M |
| Borrowings | ₩12B | ₩3.5B | ₩6.2B | ₩9.4B | ₩11B |
| Total equity | ₩23B | ₩16B | ₩19B | ₩13B | ₩10B |
| Shareholders' equity | ₩24B | ₩16B | ₩19B | ₩13B | ₩10B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩2.2B | −₩6B | −₩2.8B | −₩4.1B | −₩4B |
| Capital spending | ₩879M | ₩586M | ₩2.4B | ₩340M | ₩6.3B |
| Free cash flow | −₩3B | −₩6.5B | −₩5.2B | −₩4.4B | −₩10B |
Consolidated where available. Amounts in won.
Also known as: SCL Science / SCL사이언스 / 246960 / KRX:246960
Source: KRX statistical information